Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G Gossamer Bio, Inc. Filed by: Opaleye Management Inc.

July 29, 2026 4:06 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G




Comment for Type of Reporting Person: Based on 488,846,722 shares of Common Stock outstanding as of June 5, 2026, as reported by Gossamer Bio, Inc. in its Definitive Proxy Statement on Schedule 14A filed with the SEC on June 9, 2026.


SCHEDULE 13G





SCHEDULE 13G



Opaleye Management Inc.
Signature:/s/ James Silverman
Name/Title:President
Date:07/29/2026
Opaleye, L.P.
Signature:/s/ James Silverman
Name/Title:General Partner
Date:07/29/2026
James Silverman
Signature:/s/ James Silverman
Name/Title:Individually
Date:07/29/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement by and among the reporting persons

ATTACHMENTS / EXHIBITS

EX-99.1

Categories

SEC Filings